A medical procedure called deep cervical lymphaticovenous anastomosis is being considered for its potential use in treating Alzheimer's disease. However, its efficacy is unvalidated and it carries significant risks, which may hinder its clinical use. The procedure's potential benefits and challenges are being reexamined and researched, with some studies providing new insights into its relationship with central nervous system disease.